The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Favipiravir Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2028
Synopsis
The Favipiravir market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Favipiravir market size is estimated to be worth US$ 352.7 million in 2021 and is forecast to a readjusted size of USD 67 million by 2028 with a CAGR of -21.1% during review period. Influenza Viruses accounting for % of the Favipiravir global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Brand Drug segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Favipiravir include ChemRar Group, Glenmark, Fujifilm, Dr. Reddy, and R-Pharma, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Favipiravir market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Brand Drug
Generic Drug
Market segment by Application can be divided into
Influenza Viruses
COVID-19
Others
The key market players for global Favipiravir market are listed below:
ChemRar Group
Glenmark
Fujifilm
Dr. Reddy
R-Pharma
Cipla
Lupin
Sun Pharma
Hisun Pharm
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Favipiravir product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Favipiravir, with price, sales, revenue and global market share of Favipiravir from 2019 to 2022.
Chapter 3, the Favipiravir competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Favipiravir breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Favipiravir market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Favipiravir.
Chapter 13, 14, and 15, to describe Favipiravir sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
The Favipiravir market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Favipiravir market size is estimated to be worth US$ 352.7 million in 2021 and is forecast to a readjusted size of USD 67 million by 2028 with a CAGR of -21.1% during review period. Influenza Viruses accounting for % of the Favipiravir global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Brand Drug segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Favipiravir include ChemRar Group, Glenmark, Fujifilm, Dr. Reddy, and R-Pharma, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Favipiravir market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Brand Drug
Generic Drug
Market segment by Application can be divided into
Influenza Viruses
COVID-19
Others
The key market players for global Favipiravir market are listed below:
ChemRar Group
Glenmark
Fujifilm
Dr. Reddy
R-Pharma
Cipla
Lupin
Sun Pharma
Hisun Pharm
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Favipiravir product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Favipiravir, with price, sales, revenue and global market share of Favipiravir from 2019 to 2022.
Chapter 3, the Favipiravir competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Favipiravir breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Favipiravir market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Favipiravir.
Chapter 13, 14, and 15, to describe Favipiravir sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Favipiravir Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Favipiravir Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Brand Drug
1.2.3 Generic Drug
1.3 Market Analysis by Application
1.3.1 Overview: Global Favipiravir Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Influenza Viruses
1.3.3 COVID-19
1.3.4 Others
1.4 Global Favipiravir Market Size & Forecast
1.4.1 Global Favipiravir Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Favipiravir Sales in Volume (2017-2028)
1.4.3 Global Favipiravir Price (2017-2028)
1.5 Global Favipiravir Production Capacity Analysis
1.5.1 Global Favipiravir Total Production Capacity (2017-2028)
1.5.2 Global Favipiravir Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Favipiravir Market Drivers
1.6.2 Favipiravir Market Restraints
1.6.3 Favipiravir Trends Analysis
2 Manufacturers Profiles
2.1 ChemRar Group
2.1.1 ChemRar Group Details
2.1.2 ChemRar Group Major Business
2.1.3 ChemRar Group Favipiravir Product and Services
2.1.4 ChemRar Group Favipiravir Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Glenmark
2.2.1 Glenmark Details
2.2.2 Glenmark Major Business
2.2.3 Glenmark Favipiravir Product and Services
2.2.4 Glenmark Favipiravir Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Fujifilm
2.3.1 Fujifilm Details
2.3.2 Fujifilm Major Business
2.3.3 Fujifilm Favipiravir Product and Services
2.3.4 Fujifilm Favipiravir Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Dr. Reddy
2.4.1 Dr. Reddy Details
2.4.2 Dr. Reddy Major Business
2.4.3 Dr. Reddy Favipiravir Product and Services
2.4.4 Dr. Reddy Favipiravir Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 R-Pharma
2.5.1 R-Pharma Details
2.5.2 R-Pharma Major Business
2.5.3 R-Pharma Favipiravir Product and Services
2.5.4 R-Pharma Favipiravir Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Cipla
2.6.1 Cipla Details
2.6.2 Cipla Major Business
2.6.3 Cipla Favipiravir Product and Services
2.6.4 Cipla Favipiravir Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Lupin
2.7.1 Lupin Details
2.7.2 Lupin Major Business
2.7.3 Lupin Favipiravir Product and Services
2.7.4 Lupin Favipiravir Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Sun Pharma
2.8.1 Sun Pharma Details
2.8.2 Sun Pharma Major Business
2.8.3 Sun Pharma Favipiravir Product and Services
2.8.4 Sun Pharma Favipiravir Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Hisun Pharm
2.9.1 Hisun Pharm Details
2.9.2 Hisun Pharm Major Business
2.9.3 Hisun Pharm Favipiravir Product and Services
2.9.4 Hisun Pharm Favipiravir Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Favipiravir Breakdown Data by Manufacturer
3.1 Global Favipiravir Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Favipiravir Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Favipiravir
3.4 Market Concentration Rate
3.4.1 Top 3 Favipiravir Manufacturer Market Share in 2021
3.4.2 Top 6 Favipiravir Manufacturer Market Share in 2021
3.5 Global Favipiravir Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Favipiravir Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Favipiravir Market Size by Region
4.1.1 Global Favipiravir Sales in Volume by Region (2017-2028)
4.1.2 Global Favipiravir Revenue by Region (2017-2028)
4.2 North America Favipiravir Revenue (2017-2028)
4.3 Europe Favipiravir Revenue (2017-2028)
4.4 Asia-Pacific Favipiravir Revenue (2017-2028)
4.5 South America Favipiravir Revenue (2017-2028)
4.6 Middle East and Africa Favipiravir Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Favipiravir Sales in Volume by Type (2017-2028)
5.2 Global Favipiravir Revenue by Type (2017-2028)
5.3 Global Favipiravir Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Favipiravir Sales in Volume by Application (2017-2028)
6.2 Global Favipiravir Revenue by Application (2017-2028)
6.3 Global Favipiravir Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Favipiravir Sales by Type (2017-2028)
7.2 North America Favipiravir Sales by Application (2017-2028)
7.3 North America Favipiravir Market Size by Country
7.3.1 North America Favipiravir Sales in Volume by Country (2017-2028)
7.3.2 North America Favipiravir Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Favipiravir Sales by Type (2017-2028)
8.2 Europe Favipiravir Sales by Application (2017-2028)
8.3 Europe Favipiravir Market Size by Country
8.3.1 Europe Favipiravir Sales in Volume by Country (2017-2028)
8.3.2 Europe Favipiravir Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Favipiravir Sales by Type (2017-2028)
9.2 Asia-Pacific Favipiravir Sales by Application (2017-2028)
9.3 Asia-Pacific Favipiravir Market Size by Region
9.3.1 Asia-Pacific Favipiravir Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Favipiravir Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Favipiravir Sales by Type (2017-2028)
10.2 South America Favipiravir Sales by Application (2017-2028)
10.3 South America Favipiravir Market Size by Country
10.3.1 South America Favipiravir Sales in Volume by Country (2017-2028)
10.3.2 South America Favipiravir Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Favipiravir Sales by Type (2017-2028)
11.2 Middle East & Africa Favipiravir Sales by Application (2017-2028)
11.3 Middle East & Africa Favipiravir Market Size by Country
11.3.1 Middle East & Africa Favipiravir Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Favipiravir Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Favipiravir and Key Manufacturers
12.2 Manufacturing Costs Percentage of Favipiravir
12.3 Favipiravir Production Process
12.4 Favipiravir Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Favipiravir Typical Distributors
13.3 Favipiravir Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of TablesList of Tables
Table 1. Global Favipiravir Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Favipiravir Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. ChemRar Group Basic Information, Manufacturing Base and Competitors
Table 4. ChemRar Group Major Business
Table 5. ChemRar Group Favipiravir Product and Services
Table 6. ChemRar Group Favipiravir Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Glenmark Basic Information, Manufacturing Base and Competitors
Table 8. Glenmark Major Business
Table 9. Glenmark Favipiravir Product and Services
Table 10. Glenmark Favipiravir Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Fujifilm Basic Information, Manufacturing Base and Competitors
Table 12. Fujifilm Major Business
Table 13. Fujifilm Favipiravir Product and Services
Table 14. Fujifilm Favipiravir Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Dr. Reddy Basic Information, Manufacturing Base and Competitors
Table 16. Dr. Reddy Major Business
Table 17. Dr. Reddy Favipiravir Product and Services
Table 18. Dr. Reddy Favipiravir Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. R-Pharma Basic Information, Manufacturing Base and Competitors
Table 20. R-Pharma Major Business
Table 21. R-Pharma Favipiravir Product and Services
Table 22. R-Pharma Favipiravir Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Cipla Basic Information, Manufacturing Base and Competitors
Table 24. Cipla Major Business
Table 25. Cipla Favipiravir Product and Services
Table 26. Cipla Favipiravir Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Lupin Basic Information, Manufacturing Base and Competitors
Table 28. Lupin Major Business
Table 29. Lupin Favipiravir Product and Services
Table 30. Lupin Favipiravir Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Sun Pharma Basic Information, Manufacturing Base and Competitors
Table 32. Sun Pharma Major Business
Table 33. Sun Pharma Favipiravir Product and Services
Table 34. Sun Pharma Favipiravir Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Hisun Pharm Basic Information, Manufacturing Base and Competitors
Table 36. Hisun Pharm Major Business
Table 37. Hisun Pharm Favipiravir Product and Services
Table 38. Hisun Pharm Favipiravir Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Favipiravir Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 40. Global Favipiravir Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Favipiravir, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Favipiravir Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Favipiravir Production Site of Key Manufacturer
Table 44. Favipiravir New Entrant and Capacity Expansion Plans
Table 45. Favipiravir Mergers & Acquisitions in the Past Five Years
Table 46. Global Favipiravir Sales by Region (2017-2022) & (K Units)
Table 47. Global Favipiravir Sales by Region (2023-2028) & (K Units)
Table 48. Global Favipiravir Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Favipiravir Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Favipiravir Sales by Type (2017-2022) & (K Units)
Table 51. Global Favipiravir Sales by Type (2023-2028) & (K Units)
Table 52. Global Favipiravir Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Favipiravir Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Favipiravir Price by Type (2017-2022) & (US$/Unit)
Table 55. Global Favipiravir Price by Type (2023-2028) & (US$/Unit)
Table 56. Global Favipiravir Sales by Application (2017-2022) & (K Units)
Table 57. Global Favipiravir Sales by Application (2023-2028) & (K Units)
Table 58. Global Favipiravir Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Favipiravir Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Favipiravir Price by Application (2017-2022) & (US$/Unit)
Table 61. Global Favipiravir Price by Application (2023-2028) & (US$/Unit)
Table 62. North America Favipiravir Sales by Country (2017-2022) & (K Units)
Table 63. North America Favipiravir Sales by Country (2023-2028) & (K Units)
Table 64. North America Favipiravir Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Favipiravir Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Favipiravir Sales by Type (2017-2022) & (K Units)
Table 67. North America Favipiravir Sales by Type (2023-2028) & (K Units)
Table 68. North America Favipiravir Sales by Application (2017-2022) & (K Units)
Table 69. North America Favipiravir Sales by Application (2023-2028) & (K Units)
Table 70. Europe Favipiravir Sales by Country (2017-2022) & (K Units)
Table 71. Europe Favipiravir Sales by Country (2023-2028) & (K Units)
Table 72. Europe Favipiravir Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Favipiravir Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Favipiravir Sales by Type (2017-2022) & (K Units)
Table 75. Europe Favipiravir Sales by Type (2023-2028) & (K Units)
Table 76. Europe Favipiravir Sales by Application (2017-2022) & (K Units)
Table 77. Europe Favipiravir Sales by Application (2023-2028) & (K Units)
Table 78. Asia-Pacific Favipiravir Sales by Region (2017-2022) & (K Units)
Table 79. Asia-Pacific Favipiravir Sales by Region (2023-2028) & (K Units)
Table 80. Asia-Pacific Favipiravir Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Favipiravir Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Favipiravir Sales by Type (2017-2022) & (K Units)
Table 83. Asia-Pacific Favipiravir Sales by Type (2023-2028) & (K Units)
Table 84. Asia-Pacific Favipiravir Sales by Application (2017-2022) & (K Units)
Table 85. Asia-Pacific Favipiravir Sales by Application (2023-2028) & (K Units)
Table 86. South America Favipiravir Sales by Country (2017-2022) & (K Units)
Table 87. South America Favipiravir Sales by Country (2023-2028) & (K Units)
Table 88. South America Favipiravir Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Favipiravir Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Favipiravir Sales by Type (2017-2022) & (K Units)
Table 91. South America Favipiravir Sales by Type (2023-2028) & (K Units)
Table 92. South America Favipiravir Sales by Application (2017-2022) & (K Units)
Table 93. South America Favipiravir Sales by Application (2023-2028) & (K Units)
Table 94. Middle East & Africa Favipiravir Sales by Region (2017-2022) & (K Units)
Table 95. Middle East & Africa Favipiravir Sales by Region (2023-2028) & (K Units)
Table 96. Middle East & Africa Favipiravir Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Favipiravir Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Favipiravir Sales by Type (2017-2022) & (K Units)
Table 99. Middle East & Africa Favipiravir Sales by Type (2023-2028) & (K Units)
Table 100. Middle East & Africa Favipiravir Sales by Application (2017-2022) & (K Units)
Table 101. Middle East & Africa Favipiravir Sales by Application (2023-2028) & (K Units)
Table 102. Favipiravir Raw Material
Table 103. Key Manufacturers of Favipiravir Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Favipiravir Typical Distributors
Table 107. Favipiravir Typical Customers
List of Figures
Figure 1. Favipiravir Picture
Figure 2. Global Favipiravir Revenue Market Share by Type in 2021
Figure 3. Brand Drug
Figure 4. Generic Drug
Figure 5. Global Favipiravir Revenue Market Share by Application in 2021
Figure 6. Influenza Viruses
Figure 7. COVID-19
Figure 8. Others
Figure 9. Global Favipiravir Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Favipiravir Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Favipiravir Sales (2017-2028) & (K Units)
Figure 12. Global Favipiravir Price (2017-2028) & (US$/Unit)
Figure 13. Global Favipiravir Production Capacity (2017-2028) & (K Units)
Figure 14. Global Favipiravir Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Favipiravir Market Drivers
Figure 16. Favipiravir Market Restraints
Figure 17. Favipiravir Market Trends
Figure 18. Global Favipiravir Sales Market Share by Manufacturer in 2021
Figure 19. Global Favipiravir Revenue Market Share by Manufacturer in 2021
Figure 20. Favipiravir Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Favipiravir Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Favipiravir Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Favipiravir Sales Market Share by Region (2017-2028)
Figure 24. Global Favipiravir Revenue Market Share by Region (2017-2028)
Figure 25. North America Favipiravir Revenue (2017-2028) & (USD Million)
Figure 26. Europe Favipiravir Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Favipiravir Revenue (2017-2028) & (USD Million)
Figure 28. South America Favipiravir Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Favipiravir Revenue (2017-2028) & (USD Million)
Figure 30. Global Favipiravir Sales Market Share by Type (2017-2028)
Figure 31. Global Favipiravir Revenue Market Share by Type (2017-2028)
Figure 32. Global Favipiravir Price by Type (2017-2028) & (US$/Unit)
Figure 33. Global Favipiravir Sales Market Share by Application (2017-2028)
Figure 34. Global Favipiravir Revenue Market Share by Application (2017-2028)
Figure 35. Global Favipiravir Price by Application (2017-2028) & (US$/Unit)
Figure 36. North America Favipiravir Sales Market Share by Type (2017-2028)
Figure 37. North America Favipiravir Sales Market Share by Application (2017-2028)
Figure 38. North America Favipiravir Sales Market Share by Country (2017-2028)
Figure 39. North America Favipiravir Revenue Market Share by Country (2017-2028)
Figure 40. United States Favipiravir Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Favipiravir Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Favipiravir Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Favipiravir Sales Market Share by Type (2017-2028)
Figure 44. Europe Favipiravir Sales Market Share by Application (2017-2028)
Figure 45. Europe Favipiravir Sales Market Share by Country (2017-2028)
Figure 46. Europe Favipiravir Revenue Market Share by Country (2017-2028)
Figure 47. Germany Favipiravir Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Favipiravir Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Favipiravir Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Favipiravir Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Favipiravir Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Favipiravir Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Favipiravir Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Favipiravir Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Favipiravir Revenue Market Share by Region (2017-2028)
Figure 56. China Favipiravir Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Favipiravir Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Favipiravir Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Favipiravir Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Favipiravir Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Favipiravir Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Favipiravir Sales Market Share by Type (2017-2028)
Figure 63. South America Favipiravir Sales Market Share by Application (2017-2028)
Figure 64. South America Favipiravir Sales Market Share by Country (2017-2028)
Figure 65. South America Favipiravir Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Favipiravir Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Favipiravir Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Favipiravir Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Favipiravir Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Favipiravir Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Favipiravir Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Favipiravir Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Favipiravir Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Favipiravir Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Favipiravir Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Favipiravir in 2021
Figure 77. Manufacturing Process Analysis of Favipiravir
Figure 78. Favipiravir Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
